Aspergillus flavus endocarditis in a child with neuroblastoma

Journal of Infection

Volumn 36, Issue 1, 1998, Pages 126-127

  Kennedy, H F ^a   Simpson, E M ^a   Wilson, N ^a   Richardson, M D ^b   Michie, J R ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; CASE REPORT; CHILD; ENDOCARDITIS; FATALITY; HUMAN; MALE; MICROBIOLOGY; NEUROBLASTOMA;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; ASPERGILLUS FLAVUS; CHILD; ENDOCARDITIS; FATAL OUTCOME; HUMANS; MALE; NEUROBLASTOMA;

EID: 0031601039     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)93702-1     Document Type: Article

References (13)

1. Kuijer PM, Kuijper EJ, van den Tweel JG, van der Lelie J. Aspergillus fumigatus, a rare cause of fatal coronary artery occlusion. Infection 1992; 20: 45-47.
2. Woods GL, Wood RP, Shaw BW Jr. Aspergillus endocarditis in patients without prior cardiovascular surgery: report of a case in a liver transplant recipient and review. Rev Infect Dis 1989; 11: 263-272.
3. Duthie R, Denning DW. Aspergillus fungemia: report of two cases and review. Clin Infect Dis 1995; 20: 598-605.
4. Coutlee F, Carceller AM, Deschamps L, Kratz C, Lapointe JR, Davignon A. The evolving pattern of paediatric endocarditis from 1960 to 1985. Can J Cardiol 1990; 6: 164-170.
5. Denning DW. Treatment of invasive aspergillosis. J Infect 1994; 28: 25-33.
6. Warnock DW. Methods with antifungal drugs. In: Evans EGV, Richardson MD, eds. Medical mycology: a practical approach. Oxford: I.R.L. Press 1989: 235-259.
7. Rubinstein E, Lang R. Fungal endocarditis. Eur Heart J 1995; 16: 84-89.
8. Maderazo EG. Hickingbotham N, Cooper B, Murcia A. Aspergillus endocarditis: cure without surgical valve replacement. South Med J 1990; 83: 351-352.
9. Maartens G, Wood MJ. The clinical presentation and diagnosis of invasive fungal infections. J Antimicrob Chemother 1991; 28: 13-22.
10. Richardson MD. Newly-recognised fungal infections originating from cutaneous sites in immunocompromised patients. Rev Med Microbiol 1991; 2: 61-67.
11. Anaissie E, Bodey GP, Kantarjian H et al. New spectrum of fungal infections in patients with cancer. Rev Infect Dis 1989; 11: 369-378.
12. Hay RJ. Liposomal amphotericin B, Ambisome. J Infect 1994; 28 (Suppl. 1): 35-43.
13. Prentice AG, Warnock DW, Johnson SAN, Taylor PC, Oliver DA. Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia. J Antimicrob Chemother 1995; 36: 657-663.